School of Medicine
Showing 111-120 of 123 Results
-
Masataka Wada
Postdoctoral Scholar, Psychiatry
BioDr. Masataka (he/him/his) is a postdoctoral scholar in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. He is a board-certified psychiatrist and holds a PhD in neuroscience.
His clinical and research interests center on psychiatric disorders in treatment-resistant conditions. To address these challenges, Dr. Masataka is engaged in exploring electrophysiological, neuroimaging, and neuromodulation techniques, including repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS). He spearheaded a significant Randomized Controlled Trial (RCT) that involved 180 patients with treatment-resistant depression, aiming to develop an innovative rTMS-based treatment. His efforts have led to him receiving awards at international conferences on three occasions for his significant contributions.
Dr. Masataka's scholarly work includes publications on the electrophysiological characteristics of psychiatric disorders and the effects of neuromodulation on clinical symptoms and neuroimaging features. Additionally, he has been the recipient of two scholarships and three grants, further highlighting his contributions to the field. -
Zoey Wang
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsSleep disruptions in neurodegenerative disorders
-
Kanhao (Alex) Zhao
Postdoctoral Scholar, Psychiatry
BioDr. Zhao is a postdoctoral researcher at Stanford University specializing in computational neuroscience, neuroimaging, and integrative multi-omics approaches to brain health. His research integrates supervised and unsupervised machine learning, functional neuroimaging, microbiome sequencing, metabolomics, and large-scale clinical datasets (e.g., Alzheimer's Disease Neuroimaging Initiative and National Health and Nutrition Examination Survey) to investigate how modifiable risk factors such as obesity, diet, and gut dysbiosis contribute to accelerated brain aging, cognitive vulnerability, and psychiatric symptoms.
His work focuses on developing multimodal frameworks that combine functional brain connectivity, cognitive and emotional phenotyping, microbiome profiles, and metabolomic signatures to uncover biological mechanisms underlying early cognitive decline and neuropsychiatric disorders. Through these approaches, Dr. Zhao aims to identify personalized intervention strategies—including dietary modification, microbiome-targeted therapies, and metabolite-guided treatments—to mitigate obesity-related brain aging and reduce the risk of cognitive impairment, Alzheimer's disease, anxiety, and depression.
In addition to translational neuroscience research, Dr. Zhao develops machine learning and computational methods for biomarker discovery, disease prediction, and precision psychiatry. His recent work also explores autonomous AI research agents and self-improving computational systems for large-scale neuroimaging and multi-omics foundational analysis. His publications were in online Nature Mental Health, Molecular Psychiatry, JAMA Network Open. He serves as a peer reviewer for leading journals, including Nature Mental Health, Medical Image Analysis, IEEE Transactions on Medical Imaging, npj Digital Health, and Neuropsychopharmacology. -
Yanan Zhao
Postdoctoral Scholar, Psychiatry
BioYanan completed her Ph.D. degree at Fudan University, where she uncovered the mechanisms of sleep transitions from the evolutionary point of view in Dr Zhili Huang’s lab, with a combination of optogenetics, in vivo electrophysiology, fiber photometry, polysomnography, immunohistochemistry and so on. In the de Lecea lab, Yanan is now curious about how sleep regulates the balance between DNA damage and repair with approaches of imaging. At the same time, she is interested in larger scale imaging during different brain states. Outside the lab, Yanan enjoys biking and exploring the sunny bay area.
